News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Bertrand Delsuc: 2 IO agents discontinued at once by $MRK
Bertrand Delsuc/X
Dec 18, 2024, 12:51

Bertrand Delsuc: 2 IO agents discontinued at once by $MRK

Bertrand Delsuc, CEO and Founder at Biotellytics, shared a post on X:

“Wow, 2 IO agents discontinued at once by $MRK.

RIP anti TIGIT vibostolimab (2 NSCLC studies of pembro+visbosto declared futile+safety consistent with that observed for vibosto and pembro in previously reported studies (ie not good).

RIP anti LAG3 favezelimab (only 1 ph3 in cHL for pembro+fave) room made for the development of other candidates in $MRK’s comprehensive and diversified oncology pipeline.

Let me guess, like LM-299?

Merck $MRK Provides Update on KeyVibe and KEYFORM Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations with Pembrolizumab.”

For more updates, follow OncoDaily.

 

$MRK Bertrand Delsuc cancer Clinical Development Favezelimab OncoDaily Oncology pembrolizumab Vibostolimab
Special Coverage
Blog
Jan 17, 2025, 07:47
Salvatore La Rosa: Save the date for the most anticipated kidney cancer research event
Blog
Jan 17, 2025, 07:45
Cervical cancer is preventable and treatable when detected early - Cancer Fight Tanzania
Dialogues
Jan 17, 2025, 07:34
ASCO24 Updates: Benjamin Weinberg on Novel Immunotherapy for Pancreatic Cancer
Science
Jan 16, 2025, 23:54
ESMO Global Consortium Study on the availability and accessibility of cancer medicines
Blog
Jan 16, 2025, 23:51
Tatiana Prowell: We don’t talk enough about the grief of caregiving for loved ones
Blog
Jan 16, 2025, 23:43
Gavi, the Vaccine Alliance - Celebrating a milestone in Ethiopia’s fight against cervical cancer
Blog
Jan 16, 2025, 23:41
European Medical Organisations Unite Against Health Workforce Crisis
Blog
Jan 16, 2025, 23:37
The first South East Europe Conference on HPV - European Cancer Organisation
Science
Jan 16, 2025, 23:35
Sami (Papacek) Mansfield: How long does it really take to build a habit?
Blog
Jan 16, 2025, 23:33
Jill Feldman: If I can help one person or one family - that matters
Blog
Jan 16, 2025, 23:27
The Basic Research in Cancer Health Disparities Program - NCI Center to Reduce Cancer Health Disparities
Blog
Jan 16, 2025, 23:24
Brittney Abernathy: I will be representing Frontiers in Nuclear Medicine at EMIM 2025